News
RBC Capital Maintains Sector Perform on Nevro, Lowers Price Target to $16
15 Apr 24
News, Price Target, Analyst Ratings
Mizuho Maintains Neutral on Nevro, Lowers Price Target to $16
11 Apr 24
News, Price Target, Analyst Ratings
Wells Fargo Maintains Equal-Weight on Nevro, Lowers Price Target to $14
8 Apr 24
News, Price Target, Analyst Ratings
Where Nevro Stands With Analysts
3 Apr 24
Analyst Ratings
Citigroup Maintains Neutral on Nevro, Lowers Price Target to $16
3 Apr 24
News, Price Target, Analyst Ratings
Nevro Receives FDA 510(k) Clearance To Use SI Fixation System Without Need To Include Lateral Screw
28 Feb 24
Biotech, News, FDA, General
Analyst Scoreboard: 4 Ratings For Nevro
22 Feb 24
Analyst Ratings
Nevro Q4 2023 GAAP EPS $(0.25) Beats $(0.49) Estimate, Sales $116.18M Beat $112.48M Estimate
21 Feb 24
Earnings, Earnings Beats, News
Nevro: Q4 Earnings Insights
21 Feb 24
Earnings
Earnings Scheduled For February 21, 2024
21 Feb 24
Earnings
Press releases
Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024
17 Apr 24
Press Releases
Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-Off
9 Apr 24
News, Press Releases
Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic Neuropathy
1 Feb 24
Press Releases
Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024
29 Jan 24
Press Releases